What new biomarkers are on the horizon for severe exacerbations?

P. Burgel (Paris, France)

Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Number: 17
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Burgel (Paris, France). What new biomarkers are on the horizon for severe exacerbations?. Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019
Year: 2019



Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD?
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017


Does past experience predict future exacerbations in adults with asthma?
Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD
Year: 2010

Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
Source: Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020
Year: 2021



Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms
Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care
Year: 2010

Are severe and moderate exacerbations different entities?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021


How can we better treat infective exacerbations of COPD?
Source: Annual Congress 2012 - Prevention and treatment of infective exacerbations of COPD
Year: 2012


What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Is CRP a reliable diagnostic tool for infective exacerbations of COPD?
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death?
Source: Breathe, 17 (4) 1900164; 10.1183/20734735.0046-2021
Year: 2021



Impact of stable state symptoms on the future burden of COPD exacerbations
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Clinical clustering of COPD patients is useful to predict future COPD exacerbations
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018

Recommended new therapies for severe asthma and the future
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




How can treatable traits be used in severe exacerbations?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021



Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021


Recommendations of new therapies for severe asthma and the future
Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma
Year: 2013


A new early predictive index for hospitalisation in acute exacerbations of asthma
Source: Annual Congress 2008 - Mechanical ventilation and airway management
Year: 2008

Prediction of future COPD exacerbations - DOSE index or a history of exacerbations?
Source: International Congress 2018 – Primary care management of COPD
Year: 2018